Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02912767 | Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer | completed | — | 625 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01682213 | Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation | completed | Phase 2 | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 26, 2020 |
| clinicaltrials |
| NCT01913639 | FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 15, 2020 | clinicaltrials |
| NCT00058370 | Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma | completed | N/A | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 11, 2020 | clinicaltrials |
| NCT01872130 | Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins | completed | — | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT01916135 | PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative | completed | Phase 1 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 27, 2020 | clinicaltrials |
| NCT00597961 | Health Communication in Families | completed | — | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 16, 2020 | clinicaltrials |
| NCT02598752 | Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation | completed | — | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 16, 2020 | clinicaltrials |
| NCT02753673 | Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy | completed | — | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT02257541 | BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | completed | Phase 1 / Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 30, 2020 | clinicaltrials |
| NCT01076387 | Randomized Trial Comparing Robotic and Open Radical Cystectomy | completed | Phase 3 | 124 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 16, 2020 | clinicaltrials |
| NCT02100930 | Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma | completed | N/A | 69 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT00582348 | Physical Activity and Inactivity in Lung Cancer Survivors | completed | — | 188 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT01912131 | Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients | completed | N/A | 178 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT03159117 | Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma | completed | Phase 1 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02726399 | Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer | terminated | Phase 2 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 21, 2020 | clinicaltrials |
| NCT00586937 | Quality of Life in Lung Cancer Survivors | completed | — | 193 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT01534923 | Doctor-Patient Communication About Colorectal Cancer Screening | completed | — | 76 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT01827163 | Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2019 | clinicaltrials |
| NCT00515411 | Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 111 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 10, 2019 | clinicaltrials |
| NCT01749332 | A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections | completed | N/A | 117 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2019 | clinicaltrials |
| NCT00579007 | Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations | completed | — | 224 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT01392209 | Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT00928850 | Modifications to Radical Prostatectomy: Feasibility Study | completed | N/A | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT01114555 | Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma | completed | Phase 2 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT02091531 | Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients | completed | Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT01183884 | 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma | terminated | Phase 2 | 46 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT03120676 | Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma | terminated | Phase 2 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT02700256 | Electronic Reporting of Symptoms After Surgery | completed | — | 135 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT01492673 | Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma | completed | Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Oct 29, 2019 | clinicaltrials |
| NCT02248779 | Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation | completed | — | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 15, 2019 | clinicaltrials |
| NCT01183416 | High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation | completed | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 9, 2019 | clinicaltrials |
| NCT01856543 | Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation | completed | Phase 3 | 143 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT01248962 | Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer | completed | Phase 2 | 146 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT01589094 | Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT01058746 | Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection | completed | N/A | 331 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT02139150 | Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy | withdrawn | N/A | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT01706081 | Acupuncture for Chronic Lymphedema | completed | Phase 2 | 82 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 29, 2019 | clinicaltrials |
| NCT02928549 | Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study | completed | — | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT02572869 | Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps | completed | — | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT00820170 | Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 | completed | Phase 1 / Phase 2 | 55 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT01183429 | 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT01183897 | 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow | completed | Phase 2 | 31 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT00774436 | Study of Focal Cryoablation in Low-Risk Prostate Cancer | completed | Phase 2 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT02360111 | GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant | terminated | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT01275404 | Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program(ACT-ED) | completed | N/A | 99 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 15, 2019 | clinicaltrials |
| NCT02710058 | Experience of Arab American Women With Breast Cancer: In-depth Interviews | completed | — | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 12, 2019 | clinicaltrials |
| NCT01442051 | Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer | completed | N/A | 52 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT01016769 | Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) | completed | Phase 1 / Phase 2 | 48 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2019 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials